Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
High psychological addiction potential with compulsive redosing commonly reported. Long-acting barbiturates have moderate to high abuse potential.
Extremely physically addictive with life-threatening withdrawal potential. Abrupt discontinuation in dependent individuals may cause seizures, psychosis, and death. Medical supervision is essential for discontinuation.
Lethal in overdose; can cause coma, permanent brain injury, or death. Has been documented in suicides and mass casualty events. No specific antidote exists for barbiturate poisoning. Treatment is supportive, involving airway management, hemodialysis, and activated charcoal.
Respiratory depression is a primary toxicity concern at high doses and in overdose, potentially progressing to Cheyne-Stokes respiration, apnea, and respiratory arrest.
CNS depression ranging from sedation to coma occurs in a dose-dependent manner; severe overdose can produce EEG patterns mimicking brain death, though this is usually reversible with treatment.
Phenobarbital is a potent cytochrome P450 enzyme inducer; severe liver failure is a contraindication for use, suggesting potential hepatic burden in those with compromised liver function.
Acute renal failure may occur in massive overdose as a consequence of shock and circulatory collapse rather than direct nephrotoxicity.
Overdose can cause bradycardia, hypotension, lowered body temperature, and circulatory collapse; typical shock syndrome may develop in severe cases.
Studies have linked the use of barbiturates, particularly phenobarbital, with the development of cancer.
Psychosis is not typical during intoxication but may occur during withdrawal in physically dependent individuals. Withdrawal-induced psychosis can be severe and life-threatening.
Phenobarbital is an anticonvulsant that suppresses seizures during use. However, abrupt discontinuation in dependent individuals may paradoxically trigger severe, potentially life-threatening seizures. Drugs which lower the seizure threshold should be avoided during withdrawal.
The barbiturate class emerged in 1902 when German chemists Emil Fischer and Joseph von Mering synthesized barbital, the first compound of its kind, subsequently marketed as Veronal by Bayer. By 1904, Fischer had synthesized several related compounds including phenobarbital. The drug was introduced
UN Convention on Psychotropic Substances 1971 (Schedule IV)
Classified as a prescription-only medicine under the Poisons Standard. Legal for medical use with a valid prescription from a licensed healthcare provider.
Controlled under Schedule III of the Betäubungsmittelgesetz (Narcotics Act). Requires a narcotic prescription form for dispensing, with exceptions for preparations containing up to 10% phenobarbital or up to 300 mg per dosage unit.
Specifically named as a controlled substance under Verzeichnis B of Swiss narcotics legislation. Medicinal use is permitted with appropriate authorization.
Controlled under Schedule IV of the Controlled Substances Act. Recognized as having accepted medical use with lower abuse potential than Schedule II-III substances. Available by prescription for seizure disorders and sedation.
Controlled under the Controlled Drugs and Substances Act. Available for medical use by prescription, with restrictions on dispensing and record-keeping requirements.
Classified as a Schedule III controlled substance since 2013. However, phenobarbital remains available in over-the-counter combination medications such as Corvalol and Valocordin, which can be dispensed without a prescription.
Controlled as a Class B substance under the Misuse of Drugs Act 1971. Available for medical use by prescription, with penalties for unauthorized possession and supply.
12 sources cited